Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fc-MBL to Detect PAMPs in Septic Shock
NCT03457038Unknown
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Oct 2018
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Quantify in whole blood presence of PAMP during a septic shock at 30 days. Status: unknown.
Beyond the preview
Go deeper on NCT03457038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03457038.